CA2006425A1 - Transdermal Therapeutical System Comprising Norpseudoephedrine as Active Component - Google Patents

Transdermal Therapeutical System Comprising Norpseudoephedrine as Active Component

Info

Publication number
CA2006425A1
CA2006425A1 CA2006425A CA2006425A CA2006425A1 CA 2006425 A1 CA2006425 A1 CA 2006425A1 CA 2006425 A CA2006425 A CA 2006425A CA 2006425 A CA2006425 A CA 2006425A CA 2006425 A1 CA2006425 A1 CA 2006425A1
Authority
CA
Canada
Prior art keywords
norpseudoephedrine
active component
weight
therapeutical system
transdermal therapeutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2006425A
Other languages
French (fr)
Other versions
CA2006425C (en
Inventor
Thomas Hille
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2006425A1 publication Critical patent/CA2006425A1/en
Application granted granted Critical
Publication of CA2006425C publication Critical patent/CA2006425C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Abstract

The invention relates to a transdermal therapeutic system for applying an active substance to the skin and consisting of a backing layer impermeable to the active substance, a reservoir layer and, if appropriate, a detachable protective layer, the reservoir layer being adhesive and containing 10-90% by weight of polymer material, 0-30% by weight of softener and 0.1-20% by weight of a norpseudoephedrine.
CA002006425A 1988-12-22 1989-12-21 Transdermal therapeutical system comprising norpseudoephedrine as active component Expired - Fee Related CA2006425C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3843237.4 1988-12-22
DE3843237A DE3843237A1 (en) 1988-12-22 1988-12-22 TRANSDERMAL THERAPEUTIC SYSTEM WITH AN ANTIADIPOSITUM AS AN ACTIVE INGREDIENT

Publications (2)

Publication Number Publication Date
CA2006425A1 true CA2006425A1 (en) 1990-06-22
CA2006425C CA2006425C (en) 1995-09-05

Family

ID=6369853

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002006425A Expired - Fee Related CA2006425C (en) 1988-12-22 1989-12-21 Transdermal therapeutical system comprising norpseudoephedrine as active component

Country Status (23)

Country Link
EP (1) EP0374725B1 (en)
JP (1) JP2602108B2 (en)
KR (1) KR950015055B1 (en)
AT (1) ATE93147T1 (en)
AU (1) AU614208B2 (en)
CA (1) CA2006425C (en)
CS (1) CS8907193A3 (en)
DD (1) DD290581A5 (en)
DE (2) DE3843237A1 (en)
DK (1) DK651089A (en)
ES (1) ES2045369T3 (en)
FI (1) FI95772C (en)
HU (1) HU203280B (en)
IE (1) IE63878B1 (en)
IL (1) IL92678A (en)
MY (1) MY105074A (en)
NO (1) NO178784C (en)
NZ (1) NZ231909A (en)
PH (1) PH25854A (en)
PL (1) PL163292B1 (en)
PT (1) PT92650B (en)
YU (1) YU47075B (en)
ZA (1) ZA899879B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602912B2 (en) 2000-06-30 2003-08-05 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3939376C1 (en) * 1989-11-29 1991-05-08 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De
DE4342893C2 (en) * 1993-12-16 1999-09-23 Lohmann Gmbh & Co Kg Reversible adhesive, residue-free removable pressure sensitive adhesive, process for its production and use as re-adhesive pressure sensitive adhesive articles
JP2003528045A (en) * 1999-12-16 2003-09-24 ダーマトレンズ， インコーポレイテッド Transdermal administration of phenylpropanolamine
KR100956865B1 (en) * 2009-08-10 2010-05-11 주식회사 라이트론 Slide pressure packing type linear lighting apparatus
WO2018081761A1 (en) * 2016-10-31 2018-05-03 The Corporation Of Mercer University Transdermal delivery of phenethylamine monoamine releasers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
JPS57116011A (en) * 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
ATE42901T1 (en) * 1984-03-05 1989-05-15 Nitto Denko Corp ADHESIVE MEDICATION FOR PERCUTANEOUS ABSORPTION.
JPS60185713A (en) * 1984-03-05 1985-09-21 Nitto Electric Ind Co Ltd Percutaneous preparation and its production
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
DE3629304A1 (en) * 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg TRANSDERMAL THERAPEUTIC SYSTEM, ITS USE AND METHOD FOR THE PRODUCTION THEREOF
DE3743945A1 (en) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg DEVICE FOR DELIVERING SUBSTANCES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6602912B2 (en) 2000-06-30 2003-08-05 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers

Also Published As

Publication number Publication date
DE58905320D1 (en) 1993-09-23
KR950015055B1 (en) 1995-12-21
HU203280B (en) 1991-07-29
NO178784C (en) 1996-06-05
ATE93147T1 (en) 1993-09-15
PH25854A (en) 1991-12-02
FI95772C (en) 1996-03-25
NZ231909A (en) 1991-06-25
EP0374725A3 (en) 1990-12-19
KR900009063A (en) 1990-07-02
JP2602108B2 (en) 1997-04-23
NO895173L (en) 1990-06-25
FI896097A0 (en) 1989-12-19
ES2045369T3 (en) 1994-01-16
HUT53517A (en) 1990-11-28
ZA899879B (en) 1990-09-26
AU614208B2 (en) 1991-08-22
CA2006425C (en) 1995-09-05
FI95772B (en) 1995-12-15
JPH03123728A (en) 1991-05-27
EP0374725B1 (en) 1993-08-18
AU4684389A (en) 1990-06-28
IE894077L (en) 1990-06-22
DE3843237A1 (en) 1990-07-05
EP0374725A2 (en) 1990-06-27
DK651089A (en) 1990-06-23
IE63878B1 (en) 1995-06-14
YU240589A (en) 1991-04-30
NO178784B (en) 1996-02-26
PT92650A (en) 1990-06-29
DD290581A5 (en) 1991-06-06
YU47075B (en) 1994-12-28
DK651089D0 (en) 1989-12-20
IL92678A (en) 1994-06-24
NO895173D0 (en) 1989-12-21
MY105074A (en) 1994-07-30
PL163292B1 (en) 1994-03-31
PT92650B (en) 1995-09-12
CS275356B2 (en) 1992-02-19
HU896721D0 (en) 1990-02-28
DE3843237C2 (en) 1991-04-11
IL92678A0 (en) 1990-09-17
CS8907193A3 (en) 1992-02-19

Similar Documents

Publication Publication Date Title
MY105347A (en) Transdermal therapeutic system comprising as active component buprenorphine
PT92652A (en) METHOD FOR PREPARING A TRANSDERMM THERAPEUTIC SYSTEM CONTAINING PHYSOSTIGMINE AS ACTIVE INGREDIENT
CA2006425A1 (en) Transdermal Therapeutical System Comprising Norpseudoephedrine as Active Component

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed